Cargando…

Diagnostic antigens for visceral leishmaniasis: clarification of nomenclatures

BACKGROUND: Stimulated by the increasing recent use of ‘K’ or ‘rK’ nomenclature for antigens reported for visceral leishmaniasis (VL) diagnostic serology, we wished to give a chronological synopsis of their reporting and the potentially confusing terminology. METHODS: The literature was examined for...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharyya, Tapan, Marlais, Tegwen, Miles, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390433/
https://www.ncbi.nlm.nih.gov/pubmed/28407812
http://dx.doi.org/10.1186/s13071-017-2120-x
_version_ 1782521459626737664
author Bhattacharyya, Tapan
Marlais, Tegwen
Miles, Michael A.
author_facet Bhattacharyya, Tapan
Marlais, Tegwen
Miles, Michael A.
author_sort Bhattacharyya, Tapan
collection PubMed
description BACKGROUND: Stimulated by the increasing recent use of ‘K’ or ‘rK’ nomenclature for antigens reported for visceral leishmaniasis (VL) diagnostic serology, we wished to give a chronological synopsis of their reporting and the potentially confusing terminology. METHODS: The literature was examined for ‘K' or ‘rK’ terminology for VL diagnostic antigens, with emphasis on the original publications in which terms were first used. RESULTS: A chronological account of the first use of these 'K' and 'rK' nomenclatures was compiled. Since the original use of this terminology in 1993 in the name rK39 for a Leishmania antigen fragment, we found nine subsequent instances where ‘K' or ‘rK’ have been used to maintain consistency with this nomenclature. We also found instances where there were ambiguities regarding reported strain name, origin and GenBank accession numbers. CONCLUSIONS: We have documented here the uses in the literature of the ‘K’ or ‘rK’ prefix for VL diagnostic antigen nomenclature. We suggest that, to avoid confusion, the use of such nomenclature for future antigens should either provide the logical derivation of the term or indicate that the designation is entirely empirical.
format Online
Article
Text
id pubmed-5390433
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53904332017-04-14 Diagnostic antigens for visceral leishmaniasis: clarification of nomenclatures Bhattacharyya, Tapan Marlais, Tegwen Miles, Michael A. Parasit Vectors Review BACKGROUND: Stimulated by the increasing recent use of ‘K’ or ‘rK’ nomenclature for antigens reported for visceral leishmaniasis (VL) diagnostic serology, we wished to give a chronological synopsis of their reporting and the potentially confusing terminology. METHODS: The literature was examined for ‘K' or ‘rK’ terminology for VL diagnostic antigens, with emphasis on the original publications in which terms were first used. RESULTS: A chronological account of the first use of these 'K' and 'rK' nomenclatures was compiled. Since the original use of this terminology in 1993 in the name rK39 for a Leishmania antigen fragment, we found nine subsequent instances where ‘K' or ‘rK’ have been used to maintain consistency with this nomenclature. We also found instances where there were ambiguities regarding reported strain name, origin and GenBank accession numbers. CONCLUSIONS: We have documented here the uses in the literature of the ‘K’ or ‘rK’ prefix for VL diagnostic antigen nomenclature. We suggest that, to avoid confusion, the use of such nomenclature for future antigens should either provide the logical derivation of the term or indicate that the designation is entirely empirical. BioMed Central 2017-04-13 /pmc/articles/PMC5390433/ /pubmed/28407812 http://dx.doi.org/10.1186/s13071-017-2120-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Bhattacharyya, Tapan
Marlais, Tegwen
Miles, Michael A.
Diagnostic antigens for visceral leishmaniasis: clarification of nomenclatures
title Diagnostic antigens for visceral leishmaniasis: clarification of nomenclatures
title_full Diagnostic antigens for visceral leishmaniasis: clarification of nomenclatures
title_fullStr Diagnostic antigens for visceral leishmaniasis: clarification of nomenclatures
title_full_unstemmed Diagnostic antigens for visceral leishmaniasis: clarification of nomenclatures
title_short Diagnostic antigens for visceral leishmaniasis: clarification of nomenclatures
title_sort diagnostic antigens for visceral leishmaniasis: clarification of nomenclatures
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390433/
https://www.ncbi.nlm.nih.gov/pubmed/28407812
http://dx.doi.org/10.1186/s13071-017-2120-x
work_keys_str_mv AT bhattacharyyatapan diagnosticantigensforvisceralleishmaniasisclarificationofnomenclatures
AT marlaistegwen diagnosticantigensforvisceralleishmaniasisclarificationofnomenclatures
AT milesmichaela diagnosticantigensforvisceralleishmaniasisclarificationofnomenclatures